Resources

PharmSight Perspectives

Articles and analysis from PharmSight's teams on forecasting, market access, clinical development, commercial analytics and the therapy areas we work in.

Latest article

When a Correct KPI Tells the Wrong Story

Read article

Advanced Analytics: Commercial Excellence and Sales Force Effectiveness
When a Correct KPI Tells the Wrong Story
Abhishek Patil | 14 Oct 2026
Metabolic & Cardiometabolic
Beyond Weight Loss: The Next Chapter of GLP-1 Therapies
Priyanshu Bisht | 7 Oct 2026
Oncology · ADC Series
Beyond Conventional ADCs: The Emergence of Bispecific Antibody-Drug Conjugates (ADC 2.0)
Srinidhie Bragadesh, Ateeb Ali Khan and Ubaid Naeem | 28 Sept 2026
Clinical Development
From Drug-Centric to Patient-Centric: Rethinking Clinical Trials
Tararam Choudhary & Swati Nehra | 22 Sept 2026
Forecasting & Market Access
The Off-Label Gap: What Top-Down Forecasts Can't See
Mehul Sachdeva & Sanskruti Kharavtekar | 16 Sept 2026
Forecasting & Decision Science
Scenario Modeling in Pharma: Translating Uncertainty into Decisions
Nibir Mahanta & Shruti Bhandari | 3 Sept 2026
Organoids: Shaping the Future of Precision Medicine
Dr. Syed Sufian Ahmad | 13 Aug 2026
Market Access · Pricing Policy · Global Strategy
MFN Drug Pricing: Beyond Lower Drug Prices
Swati Nehra and Avisha Jain | 5 Aug 2026
Immunology · Cell Therapy · Emerging Frontier
The Emerging Frontier: CAR-T Therapies in Autoimmune Disorders
Ateeb Ali Khan | 28 Jul 2026

PharmSight Perspectives

When a Correct KPI Tells the Wrong Story

Beyond Weight Loss: The Next Chapter of GLP-1 Therapies

Beyond Conventional ADCs: The Emergence of Bispecific Antibody-Drug Conjugates (ADC 2.0)

From Drug-Centric to Patient-Centric: Rethinking Clinical Trials

The Off-Label Gap: What Top-Down Forecasts Can't See

Scenario Modeling in Pharma: Translating Uncertainty into Decisions

Organoids: Shaping the Future of Precision Medicine

MFN Drug Pricing: Beyond Lower Drug Prices

The Emerging Frontier: CAR-T Therapies in Autoimmune Disorders